Avandia (rosiglitazone): REMS – Risk of Cardiovascular Events
Audience: Endocrinology, Cardiology includes Avandia, Avandamet, and Avandaryl
[UPDATED 05/18/2011] FDA notified healthcare professionals and the public of new restrictions to the prescribing and use of rosiglitazone-containing medicines. These…
No related posts.




facebook
rss
twitter